Silo Pharma, Inc. (NASDAQ:SILO) Sees Significant Decrease in Short Interest

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a large decline in short interest during the month of August. As of August 31st, there was short interest totalling 134,100 shares, a decline of 25.4% from the August 15th total of 179,700 shares. Currently, 3.1% of the company’s shares are sold short. Based on an average trading volume of 5,040,000 shares, the days-to-cover ratio is currently 0.0 days.

Silo Pharma Stock Up 0.9 %

Shares of Silo Pharma stock opened at $1.11 on Monday. The company has a fifty day moving average of $1.53 and a 200-day moving average of $1.62. Silo Pharma has a 52-week low of $0.84 and a 52-week high of $4.50.

Silo Pharma (NASDAQ:SILO) last issued its earnings results on Tuesday, August 13th. The company reported ($0.31) EPS for the quarter. The firm had revenue of $0.02 million during the quarter. Silo Pharma had a negative return on equity of 55.30% and a negative net margin of 4,881.57%.

About Silo Pharma

Silo Pharma. Inc, a developmental stage biopharmaceutical company, develops traditional therapeutics and psychedelic medicine. Its lead program includes SPC-15, an intranasal drug targeting post-traumatic stress disorder (PTSD) and stress-induced anxiety disorders; and SP-26, a ketamine-based loaded implant indicated for fibromyalgia and chronic pain relief.